Biologics for Crohn's and colitis | overview

What biologics are in IBD

Common classes include anti-TNF agents, integrin inhibitors, IL-12/23 inhibitors, and JAK inhibitors for some patients. Your clinician matches class to disease type, history, and insurance.

Biologics are not interchangeable. Switching may require washout periods and new monitoring plans. Symptom patterns tracked over several days are more useful to your clinician than a single snapshot.

Biosimilars can be appropriate for some patients. Ask whether your pharmacy plans cover them. Discuss how this topic applies to your current disease activity with your gastroenterologist. Logging patterns in IBDPal or a notebook helps clinicians see trends beyond a single visit. Your GI team can adjust recommendations based on labs, imaging, and symptom trends. Second opinions are reasonable when plans feel unclear or symptoms persist despite treatment. If symptoms worsen while you try these steps, contact your clinic using your flare pathway.

Infusions, injections, and adherence

Dosing may be IV at infusion centers or subcutaneous at home. Learn storage, travel, and missed-dose rules.

Pre-medications, infusion reactions, and injection site care should be reviewed with nurses before the first dose. Write down questions for your gastroenterologist before each visit so limited appointment time is used well.

Set calendar reminders and travel letters before trips. Do not skip doses without clinician guidance. Bring these observations to your next IBD appointment so your team can personalize advice. Children, older adults, and post-surgical patients may need modified guidance from specialists. Patient education supports shared decision making; it does not replace individual medical assessment. Discuss how this topic applies to your current disease activity with your gastroenterologist. Logging patterns in IBDPal or a notebook helps clinicians see trends beyond a single visit.

Monitoring and infection prevention

TB screening, hepatitis panels, and periodic labs are standard before and during therapy.

Report fever, cough, skin changes, or neurologic symptoms promptly. Some infections need pausing therapy. Medication adherence and follow-up labs are as important as diet changes for many IBD patients.

Vaccine updates, including influenza, COVID-19, and pneumococcal vaccines per schedule, matter on immunosuppression. Your GI team can adjust recommendations based on labs, imaging, and symptom trends. Second opinions are reasonable when plans feel unclear or symptoms persist despite treatment. If symptoms worsen while you try these steps, contact your clinic using your flare pathway. Bring these observations to your next IBD appointment so your team can personalize advice.

Side effects and expectations

Not everyone responds immediately. Drug levels and calprotectin may guide dose adjustments.

Discuss risks of lymphoma, skin cancer, and liver enzyme changes in context of your personal history. Tell your team about travel, work stress, sleep changes, and menstrual cycle timing when symptoms shift.

Pregnancy planning and surgery timing need coordinated biologic plans. Involve your GI early. Patient education supports shared decision making; it does not replace individual medical assessment. Discuss how this topic applies to your current disease activity with your gastroenterologist. Logging patterns in IBDPal or a notebook helps clinicians see trends beyond a single visit. Your GI team can adjust recommendations based on labs, imaging, and symptom trends.

Insurance, prior auth, and appeals (United States)

Readers outside the United States should use our biologic access outside the U.S. and biologic questions for your doctor guides instead of U.S. payer steps below.

Biologics often require prior authorization and step therapy documentation. Start paperwork early when switching drugs.

Patient assistance programs exist for qualifying households. Clinic financial counselors can help. Bring prior colonoscopy, imaging, and pathology reports when seeing a new IBD specialist.

Keep denial letters. Appeals with medical records and symptom logs are common. If symptoms worsen while you try these steps, contact your clinic using your flare pathway. Bring these observations to your next IBD appointment so your team can personalize advice. Children, older adults, and post-surgical patients may need modified guidance from specialists. Patient education supports shared decision making; it does not replace individual medical assessment.

Practical tips

• Store injectables per label instructions.
• Carry a medication card listing your biologic and last dose.
• Report infection symptoms before your next scheduled dose.
• Ask about travel letters for airport syringes.
• Track symptoms before and after dose changes.

Related resources

• Biologic access outside the U.S.
• Biologic questions for your doctor
• Foundation medication guide
• Prior authorization guide
• Vaccines and infection risk
• Biologics and travel article
• Step therapy and Safe Step Act
• Clinical trials guide

Free tools on ibdpal.org

Track nutrition and symptoms, explore our community map, read the blog, or download the IBDPal iOS app.

Explore IBDPal →